LOGO
LOGO

Corporate News

Five Below Tanks In Pre-market; Q1 Profit Shy Of Estimates And Annual Outlook Cut Below Estimates

By RTTNews Staff Writer   ✉   | Published:   | Follow Us On Google News
rttnewslogo20mar2024

Shares of specialty discount stores chain Five Below, Inc. (FIVE) were down more than 19 percent in pre-market on Thursday to $107.07, after the company's first-quarter profit fell short of analysts' view. Five Below also cut its full-year outlook.

Net income for the first quarter declined to $31.5 million or $0.57 per share from $37.5 million or $0.67 per share in the same quarter a year ago.

Excluding one-time items, adjusted earnings of $0.60 per share missed the average estimate of analysts polled by Thomson-Reuters of $0.63 per share.

Net sales, however, increased 11.8 percent to $811.9 million from $726.2 million.

For the full year, the company now expects net sales in the range of $3.79 billion - $3.87 billion, down from the previous outlook of $3.97 billion - $4.07 billion. EPS outlook for the year has been cut to $5.00 - $5.40 from $5.71 - $6.22 earlier.

On average, 21 analysts polled by Thomson-Reuters expect the company to report earnings of $6 per share on revenue of $4.03 billion for the year.

Five Below shares had closed at $132.79, down 3.68 percent on Wednesday. The stock has traded in the range of $128.64 - $216.18 in the last 1 year.

For comments and feedback contact: editorial@rttnews.com

Business News

Get Access to Premium Stock Alerts with RTT Biotech Investor.
Global Economics Weekly Update - May 04 – May 08, 2026

May 08, 2026 15:50 ET
Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.

RELATED NEWS
Latest Updates on COVID-19